DNA-Reactive Carcinogens: Mode of Action and Human Cancer Hazard
- 1 January 2005
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 35 (8-9) , 673-683
- https://doi.org/10.1080/10408440591007278
Abstract
It has been known for decades that mutagenicity plays an important role in the activity of most carcinogens. This mutagenicity can result from direct damage to DNA through a chemical being DNA reactive or from indirect effects, such as through the production of oxygen radicals that then react with DNA. This article presents a set of key events whereby DNA reactivity initiates the process of carcinogenicity that leads to the subsequent mutation induction and enhanced cell proliferation that ultimately results in tumor development. This set of key events for DNA-reactive chemicals was applied to two case studies (aflatoxin B1 and dichloromethane) with the aim of assessing the utility of the Human Relevance Framework (HRF) for this class of chemicals. The conclusions were that the HRF was a viable approach for the use of mechanistic data for DNA-reactive chemicals obtained from both laboratory animals and human cells in vivo and in vitro for predicting human carcinogenicity. In the case of aflatoxin B1, the HRF could be used to predict that carcinogenicity in humans was a likely outcome. In contrast, the HRF predicted that the human carcinogenic potential of dichloromethane was at best less likely than in rodents; this conclusion was supported by the available epidemiological data.Keywords
This publication has 33 references indexed in Scilit:
- The formation of AFB1-macromolecular adducts in rats and humans at dietary levels of exposureFood and Chemical Toxicology, 2004
- Critical review of the epidemiology literature on the potential cancer risks of methylene chlorideInternationales Archiv für Arbeitsmedizin, 1999
- The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adductsOncogene, 1998
- Dichloromethane Metabolism to Formaldehyde and Reaction of Formaldehyde with Nucleic Acids in Hepatocytes of Rodents and Humans with and without GlutathioneS-TransferaseT1andM1GenesFundamental and Applied Toxicology, 1997
- DNA–Protein Cross-Links (DPX) and Cell Proliferation in B6C3F1Mice but Not Syrian Golden Hamsters Exposed to Dichloromethane: Pharmacokinetics and Risk Assessment with DPX as DosimeterFundamental and Applied Toxicology, 1996
- An investigation into the activation and deactivation of chlorinated hydrocarbons to genotoxins in metabolically competent human cellsMutagenesis, 1996
- Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humansToxicology and Applied Pharmacology, 1991
- In vitro binding of aflatoxin B1 and 2-acetylaminofluorene to rat, mouse and human hepatocyte DNA: the relationship of DNA binding to carcinogenicityCarcinogenesis: Integrative Cancer Research, 1988
- Metabolism of inhaled dihalomethanes in vivo: Differentiation of kinetic constants for two independent pathwaysToxicology and Applied Pharmacology, 1986
- Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver.Proceedings of the National Academy of Sciences, 1978